We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12B
AUM Growth
+$538M
Cap. Flow
+$247M
Cap. Flow %
2.05%
Top 10 Hldgs %
58.6%
Holding
1,163
New
169
Increased
414
Reduced
393
Closed
182

Sector Composition

Rank Sector Weight
1 Energy 67.66%
2 Technology 4.68%
3 Healthcare 3.47%
4 Consumer Discretionary 3.35%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHH icon
276
Choice Hotels
CHH
$5.03B
$2.76M 0.02%
22,494
+10,906
+94% +$1.37M
APH icon
277
Amphenol
APH
$188B
$2.75M 0.02%
65,392
+22,100
+51% +$951K
GD icon
278
General Dynamics
GD
$105B
$2.74M 0.02%
12,418
+3,670
+42% +$812K
MDLZ icon
279
Mondelez International
MDLZ
$77.7B
$2.74M 0.02%
39,512
+6,517
+20% +$470K
FTNT icon
280
Fortinet
FTNT
$112B
$2.72M 0.02%
46,415
-3,857
-8% -$255K
AAON icon
281
Aaon
AAON
$8.41B
$2.72M 0.02%
47,748
+42,483
+807% +$2.7M
INSM icon
282
Insmed
INSM
$23.2B
$2.68M 0.02%
106,160
+5,875
+6% +$134K
DDOG icon
283
Datadog
DDOG
$87.9B
$2.66M 0.02%
29,148
-4,453
-13% -$440K
CLNE icon
284
Clean Energy Fuels
CLNE
$447M
$2.6M 0.02%
679,871
-42,793
-6% -$191K
HLNE icon
285
Hamilton Lane
HLNE
$3.63B
$2.6M 0.02%
28,724
+6,466
+29% +$576K
CYBR
286
DELISTED
CyberArk
CYBR
$2.59M 0.02%
15,791
-1,832
-10% -$294K
FOLD
287
DELISTED
Amicus Therapeutics
FOLD
$2.58M 0.02%
211,895
+2,716
+1% +$35K
CERE
288
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$2.54M 0.02%
116,263
+984
+0.9% +$24.6K
STEM icon
289
Stem
STEM
$49.2M
$2.53M 0.02%
29,777
-1,855
-6% -$212K
ACAD icon
290
Acadia Pharmaceuticals
ACAD
$4.25B
$2.52M 0.02%
120,810
+1,274
+1% +$34.6K
TT icon
291
Trane Technologies
TT
$106B
$2.51M 0.02%
12,372
+5,707
+86% +$1.14M
XOM icon
292
ExxonMobil
XOM
$651B
$2.49M 0.02%
21,149
-5,499
-21% -$603K
CRM icon
293
Salesforce
CRM
$134B
$2.46M 0.02%
12,140
-151
-1% -$32.6K
AXSM icon
294
Axsome Therapeutics
AXSM
$12.4B
$2.43M 0.02%
34,828
+2,800
+9% +$209K
MSCI icon
295
MSCI
MSCI
$40B
$2.42M 0.02%
4,723
-4,883
-51% -$2.57M
DT icon
296
Dynatrace
DT
$12.1B
$2.42M 0.02%
51,786
+2,853
+6% +$140K
FHI icon
297
Federated Hermes
FHI
$4.4B
$2.42M 0.02%
+71,393
New +$2.46M
NFLX icon
298
Netflix
NFLX
$292B
$2.42M 0.02%
63,990
-9,190
-13% -$390K
KRYS icon
299
Krystal Biotech
KRYS
$9.88B
$2.39M 0.02%
20,620
+384
+2% +$46.8K
FLO icon
300
Flowers Foods
FLO
$1.64B
$2.33M 0.02%
104,939
-22,913
-18% -$549K

Similar funds

ALPS Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, ALPS Advisors held 1,163 positions worth $12B, up 4.7% from $11.5B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

ALPS Advisors's Q3 2023 filing shows 169 new, 414 increased, 393 reduced and 182 closed positions. Its largest new stake was Schwab Fundamental US Large Company Index ETF: 2,126,955 shares worth $39.7M. The largest sale was Magellan Midstream Partners, L.P., an estimated $827M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q3 2023 buy was Schwab Fundamental US Large Company Index ETF: 2,126,955 shares worth $39.7M.
  • ALPS Advisors added most to Enterprise Products Partners in Q3 2023, an estimated $170M increase.
  • ALPS Advisors's biggest Q3 2023 reduction was S&P Global, cutting an estimated $22.8M.
  • ALPS Advisors fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $827M.
  • ALPS Advisors's ten largest holdings make up 59% of its $12B portfolio in Q3 2023.
  • ALPS Advisors opened 169 new positions and closed 182 in Q3 2023.
  • ALPS Advisors's portfolio value rose 4.7% quarter-over-quarter to $12B.

Based on ALPS Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.